Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $14.97 million. The enterprise value is $13.47 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.54 million shares outstanding. The number of shares has increased by 1.72% in one year.
Shares Outstanding | 10.54M |
Shares Change (YoY) | +1.72% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 12.34% |
Owned by Institutions (%) | 6.83% |
Float | 5.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.08 |
Forward PS | 1.88 |
PB Ratio | 1.89 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.98 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.20.
Current Ratio | 4.06 |
Quick Ratio | 2.54 |
Debt / Equity | 0.20 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -684.50 |
Financial Efficiency
Return on equity (ROE) is -15.61% and return on invested capital (ROIC) is -9.00%.
Return on Equity (ROE) | -15.61% |
Return on Assets (ROA) | -7.96% |
Return on Capital (ROIC) | -9.00% |
Revenue Per Employee | $444,194 |
Profits Per Employee | -$41,742 |
Employee Count | 31 |
Asset Turnover | 1.28 |
Inventory Turnover | 2.21 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.88% in the last 52 weeks. The beta is 1.19, so Nephros's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -12.88% |
50-Day Moving Average | 1.65 |
200-Day Moving Average | 2.24 |
Relative Strength Index (RSI) | 36.02 |
Average Volume (20 Days) | 9,935 |
Short Selling Information
The latest short interest is 626, so 0.01% of the outstanding shares have been sold short.
Short Interest | 626 |
Short Previous Month | 2,567 |
Short % of Shares Out | 0.01% |
Short % of Float | 0.01% |
Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Nephros had revenue of $13.77 million and -$1.29 million in losses. Loss per share was -$0.12.
Revenue | 13.77M |
Gross Profit | 8.31M |
Operating Income | -1.37M |
Pretax Income | -1.29M |
Net Income | -1.29M |
EBITDA | -1.19M |
EBIT | -1.37M |
Loss Per Share | -$0.12 |
Full Income Statement Balance Sheet
The company has $3.08 million in cash and $1.58 million in debt, giving a net cash position of $1.50 million or $0.14 per share.
Cash & Cash Equivalents | 3.08M |
Total Debt | 1.58M |
Net Cash | 1.50M |
Net Cash Per Share | $0.14 |
Equity (Book Value) | 7.93M |
Book Value Per Share | 0.75 |
Working Capital | 5.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$848,000 and capital expenditures -$130,000, giving a free cash flow of -$978,000.
Operating Cash Flow | -848,000 |
Capital Expenditures | -130,000 |
Free Cash Flow | -978,000 |
FCF Per Share | -$0.09 |
Full Cash Flow Statement Margins
Gross margin is 60.38%, with operating and profit margins of -9.94% and -9.40%.
Gross Margin | 60.38% |
Operating Margin | -9.94% |
Pretax Margin | -9.40% |
Profit Margin | -9.40% |
EBITDA Margin | -8.66% |
EBIT Margin | -9.94% |
FCF Margin | -6.70% |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.72% |
Shareholder Yield | -1.72% |
Earnings Yield | -8.64% |
FCF Yield | -6.53% |
Analyst Forecast
The average price target for Nephros is $5.00, which is 252.11% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 252.11% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 10, 2019 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -12.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.34 |
Piotroski F-Score | 3 |